M. Cossburn

3.7k total citations
17 papers, 687 citations indexed

About

M. Cossburn is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, M. Cossburn has authored 17 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 5 papers in Neurology and 4 papers in Rheumatology. Recurrent topics in M. Cossburn's work include Multiple Sclerosis Research Studies (10 papers), Peripheral Neuropathies and Disorders (3 papers) and Systemic Lupus Erythematosus Research (3 papers). M. Cossburn is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Peripheral Neuropathies and Disorders (3 papers) and Systemic Lupus Erythematosus Research (3 papers). M. Cossburn collaborates with scholars based in United Kingdom and Ireland. M. Cossburn's co-authors include Gillian Ingram, Claire Hirst, Yoav Ben‐Shlomo, Neil P. Robertson, Trevor Pickersgill, Joanne Jones, Katharine Harding, Alasdair Coles, T. Pickersgill and K. Baker and has published in prestigious journals such as Brain, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

M. Cossburn

17 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Cossburn United Kingdom	10	495	241	174	150	120	17	687
George J. Hutton United States	14	619 1.3×	213 0.9×	201 1.2×	133 0.9×	188 1.6×	46	865
Alexandra Degenhardt United Kingdom	9	655 1.3×	243 1.0×	101 0.6×	218 1.5×	137 1.1×	10	769
J. Deans United Kingdom	8	621 1.3×	307 1.3×	275 1.6×	212 1.4×	139 1.2×	10	1.0k
T. Arbizu Spain	15	563 1.1×	216 0.9×	154 0.9×	165 1.1×	161 1.3×	28	745
Marc Coustans France	10	689 1.4×	338 1.4×	98 0.6×	197 1.3×	249 2.1×	10	878
N. А. Totolyan Russia	7	528 1.1×	446 1.9×	196 1.1×	153 1.0×	60 0.5×	50	720
Aurora Zanghì Italy	16	462 0.9×	169 0.7×	132 0.8×	117 0.8×	174 1.4×	50	648
Yuichi Kawata Japan	8	616 1.2×	568 2.4×	171 1.0×	178 1.2×	53 0.4×	21	873
Irmgard Mayringer Austria	6	440 0.9×	228 0.9×	209 1.2×	174 1.2×	105 0.9×	7	634
Constantinos Kilidireas Greece	13	294 0.6×	219 0.9×	74 0.4×	114 0.8×	71 0.6×	45	484

Countries citing papers authored by M. Cossburn

Since Specialization

Citations

This map shows the geographic impact of M. Cossburn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Cossburn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Cossburn more than expected).

Fields of papers citing papers by M. Cossburn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Cossburn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Cossburn. The network helps show where M. Cossburn may publish in the future.

Co-authorship network of co-authors of M. Cossburn

This figure shows the co-authorship network connecting the top 25 collaborators of M. Cossburn. A scholar is included among the top collaborators of M. Cossburn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Cossburn. M. Cossburn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Morrison, Hamish, et al.. (2023). Anti-Yo paraneoplastic cerebellar degeneration in a patient with stage IV ovarian adenocarcinoma during bevacizumab maintenance therapy. BMJ Case Reports. 16(5). e251277–e251277. 1 indexed citations

Morrison, Hamish, et al.. (2021). An important diagnostic clue for neuro-Behçet’s disease: the ‘cascade sign’. Lara D. Veeken. 61(5). e130–e131. 1 indexed citations

Harris, Matthew, M. Cossburn, & George Pengas. (2019). Multiple cerebral infarcts: a rare complication of neurosarcoidosis. Practical Neurology. 19(3). 246–249. 1 indexed citations

Azzopardi, Laura, Sara Thompson, Katharine Harding, et al.. (2013). Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 85(7). 795–798. 40 indexed citations

Harding, Katharine, M. Cossburn, Gillian Ingram, et al.. (2012). Long-term outcome of paediatric-onset multiple sclerosis: a population-based study. Journal of Neurology Neurosurgery & Psychiatry. 84(2). 141–147. 89 indexed citations

Harding, Katharine, Gillian Ingram, M. Cossburn, et al.. (2012). Genotype–phenotype correlation for non-HLA disease associated risk alleles in multiple sclerosis. Neuroscience Letters. 526(1). 15–19. 4 indexed citations

Cossburn, M., K. Baker, Gillian Ingram, T. Pickersgill, & N. P. Robertson. (2012). 129 Serum IL-21 as a biomarker in multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 83(3). e1.81–e1. 4 indexed citations

Cossburn, M., et al.. (2012). 130 A pilot study of a timed short addition test as a tool for the longitudinal study of cognitive dysfunction in multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 83(3). e1.82–e1. 1 indexed citations

Cossburn, M., Katharine Harding, Gillian Ingram, et al.. (2012). Clinical relevance of differential lymphocyte recovery after alemtuzumab therapy for multiple sclerosis. Neurology. 80(1). 55–61. 50 indexed citations

10.

Cossburn, M., George Tackley, K. Baker, et al.. (2011). The prevalence of neuromyelitis optica in South East Wales. European Journal of Neurology. 19(4). 655–659. 74 indexed citations

11.

Cossburn, M., et al.. (2011). Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis. Multiple Sclerosis Journal. 18(1). 45–54. 88 indexed citations

12.

Cossburn, M., Adrian Pace, Joanne Jones, et al.. (2011). Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort. Neurology. 77(6). 573–579. 160 indexed citations

13.

Hirst, Claire, J. Llewelyn, M. Cossburn, et al.. (2010). Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy. Journal of Neurology. 257(6). 913–919. 55 indexed citations

14.

Ingram, Gillian, Svetlana Hakobyan, Claire Hirst, et al.. (2010). Complement regulator factor H as a serum biomarker of multiple sclerosis disease state. Brain. 133(6). 1602–1611. 73 indexed citations

15.

Ingram, Gillian, et al.. (2010). Validity of patient-derived disability and clinical data in multiple sclerosis. Multiple Sclerosis Journal. 16(4). 472–479. 30 indexed citations

16.

Smith, Phil E M & M. Cossburn. (2004). Seizures: assessment and management in the emergency unit. Clinical Medicine. 4(2). 118–121. 4 indexed citations

17.

Cossburn, M., et al.. (2003). Life‐threatening thrombotic complications of relative polycythaemia. Journal of Internal Medicine. 253(4). 481–483. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact